5 Questions to Answer Before You Sign a Distribution Agreement in Southeast Asia

Signing a distribution agreement in Southeast Asia feels like the milestone. You've found a distributor, agreed on terms, negotiated exclusivity, and you're ready to start moving product. The regulatory side will sort itself out.

The registration structure in markets like Indonesia, Malaysia, and Thailand means that "the regulatory side" has implications that are embedded in your commercial relationship โ€” whether you acknowledge them in the contract or not. These five questions surface those implications before they become problems.

Question 1: Who currently holds the registrations in this market?

In Indonesia, Malaysia, and Thailand, medical device registrations cannot be held directly by a foreign manufacturer. They must be held by a local authorized representative or importer. That local entity might be the distributor you're signing with โ€” or it might be someone else entirely.

If the distributor is the registration holder, the registrations legally belong to them, not to you. If the registrations are held by a different entity (a regulatory agent, a previous distributor who was never fully transitioned), you need to understand the current status of those registrations and what will happen to them under your new arrangement.

You can check this directly: search the relevant market's registration database for your products and see what entity name appears as the license holder. In Meridian Trace, you can search by product name or your company name โ€” our OEM inference will surface registrations held under local representative names where we can identify the underlying manufacturer.

What you're looking for: Are registrations currently active? Are they held by the distributor you're about to sign with, or by a different entity? How many registrations exist and when do they expire?

Question 2: What happens to the registrations if we terminate the agreement?

This is the question most distribution agreements fail to answer clearly โ€” and the answer depends entirely on what's in the contract.

If the distributor holds the registrations in their name (which is the standard structure in Indonesia, Malaysia, and Thailand), those registrations legally belong to the distributor. When the commercial relationship ends, the registrations don't automatically transfer to you or to your new distributor. You have to negotiate a transfer โ€” and if you're terminating a difficult relationship, you're negotiating from a weak position.

A well-structured distribution agreement for these markets should specify:

  • An obligation for the distributor to cooperate with registration transfer to a manufacturer-nominated entity upon termination
  • A timeline for transfer (typically 90โ€“180 days)
  • A cooperation clause requiring the distributor to provide all registration documentation during transition
  • Financial mechanics: who pays for the transfer filing, whether there are any compensation provisions for the distributor's registration investment

Without these clauses, you're dependent on goodwill at exactly the moment goodwill is likely to be lowest.

Question 3: What other companies does this distributor represent โ€” and do they distribute competitors?

A distributor representing your product and a direct competitor's product in the same device category faces an inherent conflict of interest. They will allocate sales effort, clinical support, and promotional resources across their portfolio. The incentives are not always aligned with your interests.

Registration data can partially answer this question. Search the distributor's name (as it appears in the registration database) and look at all the products registered in their name. This shows you their complete product portfolio in that market โ€” not just what they've told you they carry. If the registration data shows them carrying a competing product that they haven't disclosed to you, that's a red flag worth raising before you sign.

The registration data has limitations here: it shows products where the distributor is the formal registration holder, but distributors can also sell products where another entity holds the registration. A thorough check combines the registration search with direct questions to the distributor and, ideally, market-level intelligence from your clinical or commercial contacts.

Check your distributor's full registration portfolio

Search any company's name in Meridian Trace to see all registrations they hold across 8 Asian markets. Understand who else they're working with before you sign. 50 free searches per month.

Start searching free โ†’

Question 4: What's the distributor's track record on registration renewals?

Registration validity is typically 5 years across Southeast Asian markets. A responsible distributor renews on time; a careless or resource-constrained one lets registrations lapse. Lapsed registrations mean you cannot legally import or sell until renewal is complete โ€” which can take months and create revenue gaps.

You can partially assess this from registration data: look at whether the distributor has existing registrations in the market, and whether any of them show as lapsed. A distributor with a portfolio of lapsed registrations for other manufacturers' products is telling you something about how they manage their regulatory responsibilities.

The questions to ask directly:

  • How many registrations are you currently managing in this market across all manufacturers?
  • Do you have dedicated regulatory staff, or is registration management handled by commercial staff?
  • Can you show me examples of registration renewal timelines you've achieved?
  • What is your process for tracking expiry dates?

These questions feel administrative, but they diagnose regulatory management capability quickly. A distributor who cannot answer them fluently is flagging a potential compliance problem.

Question 5: What's the realistic timeline for transferring registrations if we switch distributors?

Even if you address all of the above, relationships change. Distributors get acquired. Performance deteriorates. Better options emerge. You need to know, going in, what the realistic exit path looks like.

Registration transfer timelines vary by market:

  • Indonesia (BPOM): Transferring an AKL registration from one local entity to another is possible but not trivial. The timeline for a transfer filing and approval can be 3โ€“9 months depending on device class and BPOM workload. During this period, you cannot legally import under the new entity.
  • Malaysia (MDA): Transfer of MDA registrations similarly requires filing and review. Timelines are somewhat faster than Indonesia for straightforward transfers but can be extended for higher-class devices.
  • Thailand (FDA-TH): Transfer of FDA-TH registrations requires the cooperation of the current holder and filing with the Thai FDA. Timeline and complexity depend on device class.

Knowing these timelines informs how you structure the transition provisions in your original agreement. If Indonesia transfer can take up to nine months, you need your distribution agreement to require the distributor to cooperate with that process starting from termination notice โ€” not from whenever the new distributor gets their licensing in order.

A final note on using registration data in due diligence

These five questions can all be partially answered through registration data searches โ€” not completely, but substantively. Before signing a distribution agreement in any Southeast Asian market where local registration holders are required, it's worth running a registration search on:

  1. Your own company's products in that market โ€” to see current registration status and holder
  2. The prospective distributor โ€” to see their full registration portfolio and track record
  3. Key competitors โ€” to understand what distribution structures are common in your category

This takes under an hour and can surface issues that would take months to discover commercially. It's not a substitute for legal review of the distribution agreement, but it gives the legal team the right questions to ask.